Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy.
Uccello TP, Lesch ML, Kintzel SA, Gradzewicz LB, Lamrous L, Murphy SP, Fleming FJ, Mills BN, Murphy JD, Hughson A, Hannon G, Garrett-Larsen J, Qiu H, Drage MG, Ye J, Gavras NW, Keeley DC, Love TMT, Repasky EA, Lord EM, Linehan DC, Gerber SA. Uccello TP, et al. Among authors: gerber sa. Cell Death Dis. 2023 Jul 26;14(7):470. doi: 10.1038/s41419-023-05999-3. Cell Death Dis. 2023. PMID: 37495596 Free PMC article.
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy.
Gerber S, Uccello T, Lesch M, Kintzel S, Gradzewicz L, Lamrous L, Murphy S, Fleming F, Mills B, Murphy J, Hughson A, Garrett-Larsen J, Qiu H, Drage M, Ye J, Gavras N, Keeley D, Love T, Repasky E, Lord E, Linehan D. Gerber S, et al. Res Sq [Preprint]. 2023 Apr 13:rs.3.rs-2767780. doi: 10.21203/rs.3.rs-2767780/v1. Res Sq. 2023. PMID: 37090639 Free PMC article. Updated. Preprint.
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.
Khazan N, Quarato ER, Singh NA, Snyder CWA, Moore T, Miller JP, Yasui M, Teramoto Y, Goto T, Reshi S, Hong J, Zhang N, Pandey D, Srivastava P, Morell A, Kawano H, Kawano Y, Conley T, Sahasrabudhe DM, Yano N, Miyamoto H, Aljitawi O, Liesveld J, Becker MW, Calvi LM, Zhovmer AS, Tabdanov ED, Dokholyan NV, Linehan DC, Hansen JN, Gerber SA, Sharon A, Khera MK, Jurutka PW, Rochel N, Kim KK, Rowswell-Turner RB, Singh RK, Moore RG. Khazan N, et al. Among authors: gerber sa. Cancers (Basel). 2023 Jun 30;15(13):3432. doi: 10.3390/cancers15133432. Cancers (Basel). 2023. PMID: 37444542 Free PMC article.
PD-1Hi CAR-T cells provide superior protection against solid tumors.
Sailer CJ, Hong Y, Dahal A, Ryan AT, Mir S, Gerber SA, Reagan PM, Kim M. Sailer CJ, et al. Among authors: gerber sa. Front Immunol. 2023 Jun 14;14:1187850. doi: 10.3389/fimmu.2023.1187850. eCollection 2023. Front Immunol. 2023. PMID: 37388744 Free PMC article.
Effects of mammary cancer and chemotherapy on neuroimmunological markers and memory function in a preclinical mouse model.
Netherby-Winslow C, Thompson B, Lotta L, Gallagher M, Van Haute P, Yang R, Hott D, Hasan H, Bachmann K, Bautista J, Gerber S, Cory-Slechta DA, Janelsins M. Netherby-Winslow C, et al. Brain Behav Immun Health. 2023 Nov 7;34:100699. doi: 10.1016/j.bbih.2023.100699. eCollection 2023 Dec. Brain Behav Immun Health. 2023. PMID: 38058985 Free PMC article.
154 results